Ana O. Benzaquen

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure.

Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure.

Journal: Bone marrow transplantation

Published: December 01, 2025

Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post-transplant cyclophosphamide era: A GETH-TC study.

Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post-transplant cyclophosphamide era: A GETH-TC study.

Journal: British journal of haematology

Published: October 02, 2025

Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing.

Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing.

Journal: European journal of haematology

Published: September 25, 2025

EASIX Does Not Add Prognostic Value Beyond Lactate Dehydrogenase and ECOG Performance Status in CAR T-Cell Therapy: A GETH-TC Study.

EASIX Does Not Add Prognostic Value Beyond Lactate Dehydrogenase and ECOG Performance Status in CAR T-Cell Therapy: A GETH-TC Study.

Journal: Transplantation and cellular therapy

Published: August 07, 2025

Pre-infusion cytomegalovirus T-cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T-cell therapies.

Pre-infusion cytomegalovirus T-cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T-cell therapies.

Journal: British journal of haematology

Published: May 14, 2025

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma.

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma.

Journal: HemaSphere

Published: May 14, 2025

Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction.

Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction.

Journal: Clinical kidney journal

Published: May 06, 2025

Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma.

Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma.

Journal: JAMA network open

Published: February 25, 2025

Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy.

Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy.

Journal: Leukemia

Published: January 11, 2025

Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC.

Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC.

Journal: Bone marrow transplantation

Published: November 26, 2024

Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR-T Therapy.

Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR-T Therapy.

Journal: EJHaem

Published: November 18, 2024

Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model.

Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model.

Journal: EJNMMI research

Published: July 02, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026